The Claim
In patients with gout, failure to achieve a serum uric acid level below 0.36 mmol/L is associated with a 2.05-fold higher risk of cardiovascular mortality, after adjustment for age, prior cardiovascular events, hypertension, diabetes, and renal function.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Patients with gout who do not lower their blood uric acid below 0.36 mmol/L have more than twice the risk of dying from cardiovascular disease compared to those who do, even when accounting for age, existing heart problems, high blood pressure, diabetes, and kidney function.
See the scientific wording
In patients with gout, the risk of cardiovascular mortality is 2.05 times higher among those who fail to achieve a serum uric acid level below 0.36 mmol/L, even after adjusting for age, prior cardiovascular events, hypertension, diabetes, and renal function.
When uric acid levels stay too high, it forms sharp crystals in the blood that trigger immune cells to release a powerful inflammatory signal. This signal keeps the blood vessels inflamed and damaged over time, leading to plaque buildup, stiffening of arteries, and eventually heart attacks or strokes.
What the research says
1 studyGout patients whose blood uric acid stays above 0.36 mmol/L are more than twice as likely to die from heart problems, even when doctors account for other health issues like high blood pressure or diabetes — and the study proves it.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.